{"company":{"id":2438228,"name":"Encellin","domain":"encellin.com","url":"https://alion.io/company/encellin"},"section":"news","answer":"Encellin: 8 headlines on record, 3 headlines in the last 90 days. Its story counts 5 milestones.","figures":[{"label":"Headlines","value":"8"},{"label":"In 90 days","value":"3"},{"label":"Milestones","value":"5"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":7},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":5}],"news":[{"date":"2026-09-22","kind":"News","title":"Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/encellin-partners-breakthrough-t1d-advance-110400651.html"},{"date":"2026-09-22","kind":"News","title":"PRN_FinancialWrapper","source":"PRNewswire","url":"https://markets.financialcontent.com/prnews/article/bizwire-2026-9-22-encellin-partners-with-breakthrough-t1d-to-advance-immune-protected-cell-therapy-for-type-1-diabetes"},{"date":"2026-01-06","kind":"News","title":"Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes","source":"YahooFinance","url":"https://finance.yahoo.com/news/encellin-announces-interim-clinical-results-125500418.html"},{"date":"2026-01-06","kind":"Press release","title":"reported positive interim results","source":"businesswire.com","url":"https://businesswire.com/news/home/20260106978516/en/Encellin-Announces-Interim-Clinical-Results-Showing-First-in-Human-Non-Fibrotic-Engraftment-and-Viable-Encapsulated-Human-Islets-in-Subjects-with-Type-1-Diabetes"},{"date":"2023-12-20","kind":"News","title":"Encellin: $9.9 Million Raised To Pioneer Living Medicine Platforms","source":"Pulse 2.0","url":"https://pulse2.com/encellin-9-9-million-funding/"},{"date":"2023-12-13","kind":"Press release","title":"Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders","source":"businesswire","url":"https://businesswire.com/news/home/20231213146602/en/Encellin-Closes-%249.9M-Financing-Led-by-Khosla-Ventures-to-Advance-Cell-Encapsulation-Platform-for-Endocrine-Disorders"},{"date":"2021-08-05","kind":"Press release","title":"Encellin Closes $5.9M Seed Financing Co-Led by Khosla Ventures and SV Latam Capital","source":"businesswire","url":"https://businesswire.com/news/home/20210805005020/en/Encellin-Closes-%245.9M-Seed-Financing-Co-Led-by-Khosla-Ventures-and-SV-Latam-Capital"}],"story":[{"title":"Partnership Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes · tmcnet.com","url":"https://tmcnet.com/usubmit/2026/09/22/10449288.htm"},{"title":"Raised a round Venture round $9.9M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1782948/000178294823000004/"},{"title":"Raised a round Seed $5.9M · led by Khosla Ventures · businesswire","url":"https://businesswire.com/news/home/20210805005020/en/Encellin-Closes-%245.9M-Seed-Financing-Co-Led-by-Khosla-Ventures-and-SV-Latam-Capital"},{"title":"Raised a round Venture round $2.1M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1782948/000178294819000001/"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"Encellin, News. Alion, Nov 17, 2026. https://alion.io/company/encellin/news","html_url":"https://alion.io/company/encellin/news","json_url":"https://alion.io/company/encellin/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T22:23:21Z"}}